Study Name: Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
25 locations found
- Site Reference ID/Investigator# 37131
Location: Ellsworth, Maine 04605
- Site Reference ID/Investigator# 75433
Location: Baltimore, Maryland 21287
- Site Reference ID/Investigator# 65689
Location: Boston, Massachusetts 02114
- Site Reference ID/Investigator# 25587
Location: Cambridge, Massachusetts 02142
- Site Reference ID/Investigator# 25586
Location: Palisades Park, New Jersey 07650
- Site Reference ID/Investigator# 25589
Location: New York, New York 10003
- Site Reference ID/Investigator# 69836
Location: New York, New York 10029
- Site Reference ID/Investigator# 26726
Location: Durham, North Carolina 27705
- Site Reference ID/Investigator# 63243
Location: Winston-Salem, North Carolina 27157
- Site Reference ID/Investigator# 25599
Location: Norfolk, Virginia 23502
- Site Reference ID/Investigator# 49742
Location: Beverly Hills, California 90211
- Site Reference ID/Investigator# 85393
Location: Glendale, California 91204
- Site Reference ID/Investigator# 27867
Location: Miami, Florida 33143
- Site Reference ID/Investigator# 58286
Location: Tamarac, Florida 33321
- Site Reference ID/Investigator# 26183
Location: Tampa, Florida 33603
- Site Reference ID/Investigator# 25605
Location: Atlanta, Georgia 30322
- Site Reference ID/Investigator# 25594
Location: Chicago, Illinois 60612
- Site Reference ID/Investigator# 25596
Location: Detroit, Michigan 48201
- Site Reference ID/Investigator# 25606
Location: Oklahoma City, Oklahoma 73104
- Site Reference ID/Investigator# 25607
Location: Portland, Oregon 97239
- Site Reference ID/Investigator# 27402
Location: Dallas, Texas 75231
- Site Reference ID/Investigator# 25609
Location: Houston, Texas 77025
- Site Reference ID/Investigator# 81173
Location: McAllen, Texas 78503
- Site Reference ID/Investigator# 25598
Location: San Antonio, Texas 78240
- Site Reference ID/Investigator# 25616
Location: Salt Lake City, Utah 84132
|